Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SOL Global Investments Corp C.SOL

Alternate Symbol(s):  SOLCF

Healthcare Biotechnology
SOL Global Investments Corp. is a Canada-based diversified international investment and private equity holding company, which is engaged in investing in small and mid-cap sectors. The Company’s investments range from minority positions to strategic holdings with active advisory mandates with an objective of providing shareholders with a long-term return through capital appreciation, dividends... see more

Recent & Breaking News (CSE:SOL)

Scythian Biosciences Announces CEOs of Both Aphria and Liberty Health Sciences are Joining its Board

GlobeNewswire January 15, 2018

Scythian Biosciences Corp. Announces Upgrade to the OTCQB Marketplace

GlobeNewswire January 10, 2018

Scythian Biosciences Corp. Announces Proposed Up To 8 for 1 Stock Split

GlobeNewswire January 4, 2018

Scythian Announces No Material Change

GlobeNewswire December 28, 2017

Scythian Biosciences Corp. Announces Appointment of Ottis Anderson to Pro Athlete Advisory Committee

GlobeNewswire December 11, 2017

Scythian Biosciences Corp. Completes Sale of Go Green 

GlobeNewswire November 30, 2017

Scythian Retains Investor Relations Services

GlobeNewswire October 18, 2017

Scythian Biosciences Corp. Forms Professional Athlete Advisory Committee

GlobeNewswire September 27, 2017

Scythian Biosciences Corp. Appoints Chief Scientific Officer

GlobeNewswire September 5, 2017

Scythian Biosciences Corp. Applies for Listing of Common Stock on NASDAQ

GlobeNewswire August 29, 2017

Scythian Biosciences Corp. Retains The Weinberg Group To Provide FDA Consulting Services

GlobeNewswire August 28, 2017

Scythian Biosciences Corp. Retains Hybrid Financial Ltd. for Investor Relations Activities

GlobeNewswire August 17, 2017

Scythian Biosciences Corp. Begins Trading on the TSXV under Symbol "SCYB"

Canada NewsWire August 8, 2017